FIELD: medicine.
SUBSTANCE: method includes daily introduction of ribavirin, and also introduction of interferon daily or every second day and introduction of interleukin-1 within periodic courses three-four weeks each which include introduction of interleukin-1 every second day with an interval of five to nine weeks.
EFFECT: use of the invention enables higher clinical effectiveness in chronic viral hepatitis C, providing a sparing dose regimen of interleukin-1 and reducing probability of side effects.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PROVIDING HIGHER EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2011 |
|
RU2468815C1 |
METHOD OF CLINICAL NUTRITION OF PATIENTS SUFFERING FROM CHRONIC HEPATITIS C AND BEING ON INTEGRATED ANTIVIRAL THERAPY | 2008 |
|
RU2373952C1 |
CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
METHOD OF TREATING MODERATELY ACTIVE AND REPLICATIVE CHRONIC VIRAL HEPATITIS TYPE C OF 1-GENOTYPE | 2009 |
|
RU2398582C1 |
METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C WITH MEDICATIONS IN LIPOSOMAL FORM | 2011 |
|
RU2475263C1 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C | 2011 |
|
RU2459629C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C, GENOTYPE 3a | 2009 |
|
RU2400229C1 |
COMPOSITION FOR TREATING HEPATITIS C AND METHOD OF TREATING HEPATITIS C | 2010 |
|
RU2447899C2 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
Authors
Dates
2011-09-27—Published
2010-06-30—Filed